Previous 10 | Next 10 |
2023-12-13 12:05:17 ET Summary Peter Lynch recently pointed out that mega-cap tech stocks are likely overvalued and also shared the segment of the market that he "absolutely" likes right now. We explore why he is bullish on this segment of the market. We also compare two ETFs ...
2023-11-21 05:16:12 ET Summary IDEX Corp. has seen a decline in operating momentum, with negative organic growth and slower orders in the second and third quarters. The company operates in mission-critical niches, delivering industrial and technology solutions to various industrie...
2023-11-13 17:05:38 ET Summary Ingersoll Rand, a niche industrial products company, has seen its stock soar over the past year or so. The company has shown strong financial performance, with revenue up 17.8% and net income skyrocketing from $387.3 million to $548.9 million. Ma...
2023-11-06 12:46:01 ET Summary IDEX reported -11% organic order growth and -6% organic revenue growth in Q3 FY23. The Health & Science Technologies segment declined by 15% in organic revenue, driven by weak demand and destocking challenges. The management expects a recover...
2023-11-05 04:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-10-30 16:50:21 ET More on IDEX IDEX Corporation (IEX) Q3 2023 Earnings Call Transcript IDEX: Current Health And Science Segment Weakness Creates A Good Entry Point IDEX: Slow And Steady Wins The Race IDEX appoints Abhi Khandelwal as CFO IDEX Non-...
IDEX Corporation (NYSE:IEX) today announced that it has entered into a definitive agreement to acquire STC Material Solutions (“STC”), an integrated provider of advanced material science solutions, from Artemis for cash consideration of $206 million USD, subject to customary post-...
2023-10-26 16:58:05 ET IDEX Corporation (IEX) Q3 2023 Results Conference Call October 26, 2023 10:30 AM ET Company Participants Allison Lausas - Interim CFO & CAO Eric Ashleman - CEO and President Conference Call Participants Deane Dray - RBC Capital ...
2023-10-25 16:39:29 ET More on IDEX IDEX: Current Health And Science Segment Weakness Creates A Good Entry Point IDEX Non-GAAP EPS of $2.12 beats by $0.24, revenue of $793.4M beats by $0.91M IDEX Corp names Allison Lausas as interim Chief Financial Officer Fo...
2023-10-25 16:33:18 ET More on IDEX IDEX: Current Health And Science Segment Weakness Creates A Good Entry Point IDEX: Slow And Steady Wins The Race IDEX Corporation (IEX) Q2 2023 Earnings Call Transcript IDEX Corp names Allison Lausas as interim Chief Financ...
News, Short Squeeze, Breakout and More Instantly...
2024-04-24 12:04:16 ET Revenue growth has been positive due to strong price/cost performance. Despite market challenges, cash flow increased by 6%. Operating expenses decreased, and net income margin slightly declined. Management focused on cost management and risk assessment, with market ris...
First Quarter 2024 Highlights (All comparisons are against the first quarter of 2023 unless otherwise noted) Sales of $801 million, down 5% overall and 6% organically, in line with expectations Reported diluted EPS of $1.60, down 13%, and adjusted diluted EPS of $1.88, down 10%,...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...